Cleared Traditional

K203579 - Infinity Gateway Suite

K203579 is the FDA 510(k) clearance for Infinity Gateway Suite by Draeger Medical Systems, Inc.. It is a Class 2 Cardiovascular device (product code MSX) cleared through the Traditional 510(k) pathway after a 547-day FDA review.

K203579 · Draeger Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
547d
Days
Class 2
Risk

K203579 is an FDA 510(k) clearance for the Infinity Gateway Suite. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Draeger Medical Systems, Inc. (Andover, US). The FDA issued a Cleared decision on June 7, 2022 after a review of 547 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Draeger Medical Systems, Inc. devices

Submission Details

510(k) Number K203579 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 07, 2020
Decision Date June 07, 2022
Days to Decision 547 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
422d slower than avg
Panel avg: 125d · This submission: 547d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 69
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K203579.
CNS-2101 Central Monitor
K223567 · Nihon Kohden Corporation · Jul 2023
Everion+ System
K213863 · Biofourmis Singapore Pte., Ltd. · Feb 2023
Current Health System
K222550 · Current Health , Ltd. · Nov 2022
eCareManager 4.5
K211046 · Visicu, Inc. · Jun 2022
BeneVision Central Monitoring System
K220058 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2022
Zyter RPM
K212622 · Zyter, Inc. · Feb 2022